Photo credit: Gérard Sirois
Linda Wilhelm, President of the Canadian Arthritis Patient Alliance, had an interview with Jonna Brewer and Vanessa Blanch of CBC. Wilhelm shares her view on New Brunswick’s plans, or lack thereof, for a catastrophic drug plan on CBC’s Information Morning Moncton. Please click here to listen to the interview.
Health care costs New Brunswick more than $3 billion a year, a 40 per cent of the provincial’s budget. An estimated 70,000 families have no drug coverage.
In an interview with The Canadian Press, Health Minister Hugh Flemming proposed that a complete prescription and catastrophic drug program will be implemented before the next election. In the interview, Flemming said: “I’ll set my career on it. We’re going to have a prescription drug plan so that every New Brunswicker will have prescription drug coverage. The expensive drugs will be covered. We’re also including hypertension, diabetes and all the other kinds of drugs so that all New Brunswickers in need, who have to have drug coverage, are going to get it. It’s going to give us preventative medicine and save us a ton of money down the road.”
Critics say there is a lack of information on how the New Brunswick government’s plan to implement their promised catastrophic drug program. What difficulties do you experience in obtaining medications in New Brunswick? What do you think the government should do?
Inside the Victoria Arthritis Centre
Arthritis can strike at any age. Whether you’re diagnosed when you’re just starting out in your working life, have only been established in your career for a short time, or are approaching retirement, what will that mean for you? In some cases, it could lead to work disability, but occupational therapy can delay or prevent that possibility. Find out how. Continue reading
Photo Credit: By KROMKRATHOG/FreeDigitalPhotos.net
Medeo is an online tool that allows patients to connect with a healthcare provider and ask questions about arthritis and other health problems. Medeo is a Vancouver-based telehealth company and their tool “Medeo” is developed by a team of physicians and technologists who are committed to improving access to healthcare. You can refer to the January 2013 issue of JointHealth™ monthly to learn more about electronic health. Continue reading
New legislation has led to increased roles and responsibilities for pharmacists and an evolution in the way pharmacists interact with patients. To get a sense of what that means for arthritis consumers, we spoke with Arthritis Research Centre of Canada (ARC) research scientist, Dr. Carlo Marra…
Fact: One in six people over the age of fifteen lives with a form of arthritis.
Fact: Someone going to a pharmacist complaining of joint pain likely has osteoarthritis.
Fact: One of the largest selling classes of prescription medications are for arthritis, with biologic response modifiers (used to treat inflammatory forms) being particularly costly.
For pharmacies, this means that people with arthritis represent a large and important customer base. For provincial health ministries, arthritis is a significant expense.
The need for pharmacists to be educated about arthritis is an important message Arthritis Consumer Experts (ACE) is communicating to pharmacies and to government healthcare officials. It makes good, economical sense for both to ensure pharmacists have arthritis training. Most importantly, the enhancement will improve health outcomes.
Out of recognition for this need, ACE, the Arthritis Research Centre of Canada, and Shoppers Drug Mart/Pharmaprix formed a partnership that is providing Canadians with an important opportunity to get screened for the most common types of arthritis and is making a significant difference in the lives of individuals living with the disease and their families.
To learn more about this partnership, please click here.
The bacteria responsible for gum diseases could be the culprit for your rheumatoid arthritis (RA) pains. A recent study published in Pathogens of the University of Louisville School of Dentistry Oral Health and Systemic Diseases indicates that this bacteria worsens RA by causing an earlier onset, faster progression and increasing the severity of the disease. This means that there will be increased bone and cartilage destruction.
Photo credit: By Gregory Szarkiewicz/FreeDigitalPhotos.net
When you have gum diseases, your mouth produces an enzyme called peptidylarginine deiminanse (PAD) which, in a lab setting, caused a form of arthritis called collagen-induced arthritis. PAD alters your protein causing your body to recognize your proteins as intruders. In turn, this leads to an immune attack and thereafter, chronic inflammation. Continue reading